A Discussion with Healthcare Private Equity Executives on Life with COVID
Join Wyatt Ritchie, Managing Director at Cain Brothers, as he interviews the following healthcare private equity executives to discuss life with COVID-19 and investment strategies moving forward:
- Benjamin Edmands, Managing Partner & Co-Founder, Consonance Capital Partners
- Marty Felsenthal, Partner, Health Velocity Capital
- Gregory Moerschal, Managing Partner, Beecken Petty O'Keefe & Company
Benjamin Edmands is a Managing Partner and Co-Founder of Consonance Capital Partners. Prior to founding CCP, he was a Managing Director at JPMP, where he co-led the Healthcare Group. Ben joined JPMP in 1993 and served on numerous boards, including Big Rock, CareMore, DJO, LHP Hospital Group, MedQuest, National Surgical Care, and Warner Chilcott, Inc. He currently serves on the Board of Enclara Healthcare, Turn-Key Health, Bako Diagnostics, Orsini Pharmaceutical Services, CityMD and the Mount Sinai’s Children’s Environmental Health Center. Additionally, he is the Chairman of Harvard T. H. Chan School of Public Health’s Health Policy and Management Executive Council. Benjamin holds a BA from Colgate University and an MBA from Columbia Business School.
Marty has worked exclusively with innovative, disruptive, and rapidly growing healthcare software and services companies for more than 20 years and has led investments in companies such as TelaDoc (NYSE: TDOC); Change Healthcare (acquired by Emdeon); Aperio (acquired by Leica Biosystems); Titan Health (acquired by United Surgical Partners); US Renal Care (acquired by Leonard Green); Payerpath (acquired by Misys/Allscripts); Vantage Oncology (acquired by McKesson); NovoLogix (acquired by CVS Health); VeriCare (acquired by MedOptions); OnShift; ClearData Networks; IVX Health; MDLIVE; and Well Health. Marty was previously a partner at two leading venture and growth capital firms focused on this sector - Salix Ventures and HLM Venture Partners - and also worked with Madison Dearborn Partners earlier in his career. He also serves as an adviser to the California Healthcare Foundation Innovation Fund. Marty received his AB from Princeton University and his MBA from the Stanford University Graduate School of Business.
Greg is the Managing Partner of BPOC. He joined the firm as a Partner in 1997, commensurate with the closing of Fund I. Prior to that, Greg was a senior healthcare research analyst at ABN AMRO, after previously being a healthcare investment banker with Ken O’Keefe and David Beecken at First Chicago.
Greg serves or has served on the board of directors of Cranial Technologies, Inc., EMSI, Genezen Healthcare, Inc., Genoa Healthcare, Hospital Physician Partners, The Hygenic Corporation, Maxor National Pharmacy Services, Medical Solutions, Medicus Healthcare Solutions, NetRegulus, Inc., NeuroSource, Inc., Preferred Homecare, RSA Medical, Take Care Health Systems, TIDI Products and Zenith American Solutions, Inc.
Greg received a B.A. degree in economics from Northwestern University and an M.B.A. degree in finance and health services administration from the Northwestern University Kellogg Graduate School of Management.